Fig. 3From: Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetesCorrelation between ΔLp-PLA2 and ΔHOMA-IR in diabetic patients after CSII (r = 0.590, P < 0.05) (a); correlation between ΔsPLA2 and ΔHOMA-IR in diabetic patients after CSII (r = 0.476, P < 0.05) (b). Values of P < 0.05 are statistically significant. ΔLp-PLA2, change in Lp-PLA2 levels; ΔsPLA2, change in sPLA2 levels; ΔHOMA-IR, change in homeostatic model assessment for insulin resistanceBack to article page